BY ALBERT RONNING-ANDERSSON社区股东
-
CHMP recommends eight new medicines in November
At the very same time, the CHMP provides thumbs to 2 medications assessed by the professional panel.
-
Home-Selling Checklist: 12 Things To Do Before Selling Your House
Preparing yourself to offer your residence? After that it’s time to roll up your sleeves and reach function due to the fact that there are lots of points to do prior to notin…
-
ALK to double investment in R&D to expand pipeline
ALK anticipates to spend a harsh USD 70 million in r & d by 2024.
-
Novo Holdings expands stake in Alentis Therapeutics as part of new major investment
With a capital injection of roughly USD 140 million, Alentis Therapeutics can begin scientific trials with two most cancers candidates.
-
Demant still sees growth opportunities in new area of diagnostics business
Though Demant’s comparatively new concentrate on the analysis and remedy of balance-related issues is at the moment struggling, the CEO of Demant nonetheless has nice confidence wi…
-
GN’s US online store is still making losses – but breakeven is approaching
By late 2025 or early 2026, the listening to firm expects to have black figures on the underside line.
-
ALK eyes top sales potential from ARS license in mid-2030s after overcoming shift challenges
Not till the mid-2030s does ALK anticipate to peak potential gross sales from the nasal spray Neffy, for which the Danish firm simply purchased licensing rights in a helpful contra…
-
Novo Nordisk acquires US facility for API manufacturing
The manufacturing facility will certainly create energetic components for “future Novo Nordisk items”.
-
Novo Nordisk acquires US facility for API manufacturing
The factory will produce active ingredients for “future Novo Nordisk products”.
-
CEO sees a way for GN around Trump’s tariff wall
In 2023, GN produced 38% of complete earnings in The United States and Canada.